Mostrando 10 resultados de: 19
Publisher
New England Journal of Medicine(3)
The Lancet(3)
Canadian Journal of Cardiology(2)
Gastroenterology(2)
Stroke(2)
Área temáticas
Enfermedades(17)
Medicina y salud(12)
Farmacología y terapéutica(8)
Fisiología humana(3)
Problemas sociales y servicios a grupos(3)
Área de conocimiento
Enfermedad cardiovascular(14)
Medicina interna(10)
Medicamento(3)
Cáncer(1)
Epidemiología(1)
Heart Failure in Africa, Asia, the Middle East and South America: The INTER-CHF study
ArticleAbstract: Background There are few data on heart failure (HF) patients from Africa, Asia, the Middle East andPalabras claves:epidemiology, Global Health, Heart Failure, registryAutores:Alhabib K.F., Badr A., Balasubramanian K., Belley-Cote E.P., Damasceno A., Dokainish H., Elmaghawry M., ElSayed A., Grinvalds A., Harkness K., Huffman M.D., Karaye K.M., Lanas F., McKelvie R., Mondo C.K., Orlandini A., Palileo-Villaneuva L., PATRICIO LOPEZ -JARAMILLO, Prabhakaran D., Roy A., Sliwa K., Teo K.K., Tibazarwa K., Yacoub M.H., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusFixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis
ArticleAbstract: Background: In randomised controlled trials, fixed-dose combination treatments (or polypills) have bPalabras claves:Autores:Avezum A.J., Bangdiwala S.I., Bosch J.J., Castellano J.M., Dagenais G.R., Dans A.M., DIaz R., Fuster V., Gamra H., Gao P., Huffman M.D., Joseph P.G., Liu L., Lonn E.M., Malekzadeh R., Pais P., PATRICIO LOPEZ -JARAMILLO, Prabhakaran D., Rodgers A., Roshandel G., Sliwa K., Teo K.K., Xavier D., Yusuf S., Zhu J.Fuentes:googlescopusBlood-pressure and cholesterol lowering in persons without cardiovascular disease
ArticleAbstract: BACKGROUND Elevated blood pressure and elevated low-density lipoprotein (LDL) cholesterol increase tPalabras claves:Autores:Accini J.L., Avezum A.J., Bosch J.J., Chazova I.E., Dagenais G.R., Dans A.M., DIaz R., Held C., Jansky P., Jung H., Keltai K., Keltai M., Khunti K., Leiter L.A., Lewis B.S., Liu L., Lonn E.M., McKelvie R., Pais P., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Peters R.J.G., Piegas L.S., Pogue J., Reid C.M., Sliwa K., Toff W.D., Varigos J.D., Xavier D., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusBlood-pressure lowering in intermediate-risk persons without cardiovascular disease
ArticleAbstract: BACKGROUND Antihypertensive therapy reduces the risk of cardiovascular events among high-risk personPalabras claves:Autores:Avezum A.J., Bosch J.J., Chazova I.E., Dagenais G.R., Dans A.M., DIaz R., Held C., Jansky P., Jung H., Keltai K., Keltai M., Khunti K., Leiter L.A., Lewis B.S., Liu L., Lonn E.M., McKelvie R., Molina D.I., Pais P., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Peters R.J.G., Piegas L.S., Pogue J., Reid C.M., Sliwa K., Toff W.D., Varigos J.D., Wilkinson J., Xavier D., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusCorrigendum to "heart failure in low- and middle-income countries: Background, rationale, and design of the INTERnational Congestive Heart Failure Study (INTER-CHF)" (Am Heart J. (2015) 170:4 (627-634))
OtherAbstract:Palabras claves:Autores:Alhabib K.F., Badr A., Belley-Cote E.P., Damasceno A., Dokainish H., Elmaghawry M., ElSayed A., Grinvalds A., Harkness K., Huffman M.D., Karaye K.M., Lanas F., McKelvie R., Mondo C.K., Orlandini A., Palileo-Villaneuva L., PATRICIO LOPEZ -JARAMILLO, Prabhakaran D., Roy A., Sliwa K., Teo K.K., Yusoff K., Yusuf S., Zhu J.Fuentes:scopusAntihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Tria
ArticleAbstract: Background and Purpose: The HOPE-3 trial (Heart Outcomes Prevention Evaluation-3) found that antihypPalabras claves:Blood pressure, candesartan, Cardiovascular disease, Lipoprotein, Primary Prevention, statinAutores:Avezum A.J., Bosch J.J., Chazova I.E., Dagenais G.R., Gao P., Hart R.G., Held C., Khunti K., Leiter L.A., Lewis B.S., Lonn E.M., Pais P., PATRICIO LOPEZ -JARAMILLO, Peters R.J.G., Reid C.M., Sliwa K., Toff W.D., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusBleeding and New Cancer Diagnosis in Patients With Atherosclerosis
ArticleAbstract: BACKGROUND: Patients treated with antithrombotic drugs are at risk of bleeding. Bleeding may be thePalabras claves:aspirin, hemorrhage, neoplasms, rivaroxabanAutores:Aboyans V., Alings M., Anand S.S., Avezum A.J., Berkowitz S.D., Bhatt D.L., Bosch J.J., Connolly S.J., Cook-Bruns N., Eikelboom J.W., Felix Camilo, Fox K.A.A., Hart R.G., Maggioni A.P., Moayyedi P., O’Donnell M., Rydén L.E., Shestakovska O., Verhamme P.B., Widimsky P., Yusuf S., Zhu J.Fuentes:googlescopusGlobal mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study
ArticleAbstract: Background Most data on mortality and prognostic factors in patients with heart failure come from NoPalabras claves:Autores:Abdullah A., Ai F., Alhabib K.F., Anaya M.B., Badr A., Bai X., Balasubramanian K., Bangdiwala S.I., Belley-Cote E.P., Bhardwaj A.K., Bourke P., Campos R., Chacón C., Chaturvedi V., Chen X., Chen Y., Cursack G., Damasceno A., de Salazar D.I.M., Diez F., Dokainish H., Elmaghawry M., ElSayed A., Escobar C., Freddy O. Trujillo Cruz, Gao M., Garcia C., Ge C., Gokhale G.K., Gomez E., Grinvalds A., Gupta R., Harkness K., Hassan M.R.A., He Y., HOMINAL M.A., Honnutagi R., Huang W., Huffman M.D., Ingaramo A., Islam S., Jaramillo M.L., Jiang H., Joshi P., Karaye K.M., Kucharczuk G., Ladhani S., Lanas F., Lanas F.T., León M.B., Liang T., Liang X., Liao Y., Liu S., Lu L., Luo Y., McKelvie R., Mendoza J.L.A., Mondo C.K., Montalvo L.A.F., Nahuelpan L., Navas A.T., Negi P.C., Olivares C., Orlandini A., Palileo-Villaneuva L., Patiño E.P., PATRICIO LOPEZ -JARAMILLO, Pelliza M., Perugachi C., Prabhakaran D., Qin S., Quiroz F., Reddy N., Riquelme R., Rodríguez M.J., Rojas A., Roy A., Sliwa K., Sotomayor M.S., Tan G., Tan H., Teo K.K., Tibazarwa K., Vilamajo O.G., Villani A., Wagdy K., Wang T., Wang X., Wei F., Xiao F., Yacoub M.H., Yusoff K., Yusuf S., Zapata G., Zhang B., Zheng T., Zhu J.Fuentes:scopusLowering cholesterol, blood pressure, or both to prevent cardiovascular events: Results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants
ArticleAbstract: Aims: Rosuvastatin (10 mg per day) compared with placebo reduced major adverse cardiovascular (CV) ePalabras claves:Cardiovascular disease, Primary Prevention, statinsAutores:Avezum A.J., Bosch J.J., Dagenais G.R., Dans A.M., DIaz R., Held C., Jansky P., Joseph P.G., Jung H., Keltai K., Keltai M., Khunti K., Leiter L.A., Lewis B.S., Liu L., Lonn E.M., Pais P., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Peters R.J.G., Piegas L.S., Reid C.M., Sliwa K., Toff W.D., Varigos J.D., Xavier D., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusLong-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial
ArticleAbstract: Aims: To describe outcomes of patients with chronic coronary artery disease (CAD) and/or peripheralPalabras claves:aspirin, Coronary artery disease, Peripheral artery disease, rivaroxabanAutores:Aboyans V., Alings M., Anand S.S., Avezum A.J., Bangdiwala S.I., Bhatt D.L., Bosch J.J., Branch K.R.H., Camillo Felix, Commerford P.J., Connolly S.J., Dagenais G.R., Dans A.L., DIaz R., Eikelboom J.W., Ertl G., Fox K.A.A., Guzik T.J., Hori M., Ibrahim K.S., Kakkar A.K., Keltai K., Keltai M., Kim J.H., Lamy A., Lanas F., Leong D.P., Lewis B.S., Liang Y., Lonn E.M., Lopez-Jaramillo P., Maggioni A.P., Metsarinne K.P., Muehlhofer E., Neumann C., O’Donnell M., Parkhomenko A.N., Piegas L.S., Pogosova N., Probstfield J.L., Rydén L.E., Sharma M., Steg P.G., Stoerk S., Tasto C., Tonkin A.M., Torp-Pedersen C., Tyrwitt J., Vanassche T., Varigos J.D., Verhamme P.B., Vinereanu D., Widimsky P., Yusuf S., Zhu J.Fuentes:scopus